C12N 2710/16433
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2710/16433 (Use of viral protein as therapeutic agent other than vaccine) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 5
- Assignees
- 3
- Inventors
- 8
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Peptide inhibitors for chromodomain helicase dna binding protein 4 (chd4)11 Sep 2025US 2025/0282834 A1The Regents of the University of California
- vIRF3-Derived Peptide and Use Thereof for Preventing or Treating Cancer21 Aug 2025US 2025/0263444 A1Korea University Research and Business Foundation, Sejong Campus
- Transcription active complex targeting cancer drug from viral protein sequence30 Nov 2023US 2023/0382953 A1The Regents of the University of California
- Peptide inhibitors of hausp deubiquitinase19 Jul 2018US 2018/0201654 A1
- Peptide inhibitors of hausp deubiquitinase13 Mar 2014US 2014/0073585 A1University of Southern California
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.